[1]
2025. The influence of sodium-glucose co-transporter-2 inhibitors on the risk of cancer therapy-related cardiac dysfunction: A meta-analysis. Biomolecules and Biomedicine. 25, 8 (Mar. 2025), 1723–1736. DOI:https://doi.org/10.17305/bb.2025.11847.